Pages
Products
- Residual Protein Testing
- Endotoxin Testing
- 5' Capping Efficiency Testing
- Residual DNA Testing
- dsRNA Testing
- eGFP mRNA
- mCherry mRNA
- FLuc mRNA
- Cre mRNA
- hEPO mRNA
- 5MG Encapsulation
- 1MG Encapsulation
- 500UG Encapsulation
- OVA mRNA
- OVA mRNA Quantity
- hEPO mRNA Quantity
- Cre mRNA Quantity
- FLuc mRNA Quantity
- mCherry mRNA Quantity
- eGFP mRNA Quantity
Posts by category
- Category: News & Insights
- Speaking of Mol Bio Podcast: Therapeutic nucleic acids—A CDMO’s view on mRNA
- Absolute Gene-ius Podcast: Helping Democratize Access and Use of mRNA Technology
- FDA Guidance on Platform Technology Designation Program for Drug Development
- The Benefits of Partnering with a US-Based CDMO: Quality, Efficiency, and Peace of Mind
- October Newsletter
- Vernal Showcases Innovations at mRNA Health Conference
- Cas9 mRNA: Gene Editing Advantages
- Vernal Scales Up mRNA Production Successfully
- mRNA Tech Revolutionizes Antibody Engineering
- Vernal Enters ‘Mass Hiring Mode’ Post-Funding
- Vermont Startup Secures $21M for mRNA
- Colchester’s Vernal Biosciences Raises $20 Million to Expand
- Burlington Tech Startup Raises Funds for Growth
- Vernal Biosciences Raises $21M for mRNA Growth
- Vernal Biosciences awarded nearly $100k in Vermont Training Grant
- Vernal to Expand mRNA Team Threefold
- Colchester mRNA lab putting local college grads to work
- Colchester Startup Advances mRNA Applications
- Vernal Biosciences CEO Discusses DNA Utilization
- Vernal Biosciences Manufactures mRNA That’s Revolutionizing Medicine
- Category: Press Releases
- Vernal Biosciences Announces Partnership with REPROCELL
- Vernal featured on Businesswire
- Vermont Celebrates Vernal Success in a VT Digger Article
- Vernal Biosciences Featured in Endpoints News
- Vernal Biosciences highlighted in article by Pharma’s Almanac!
- Vernal’s growth plan going according to plan!
- Vernal Democratizes mRNA Manufacturing Access
- Category: Resources
- The mRNA Monthly—August 2024 Newsletter
- The mRNA Monthly—July 2024 Newsletter
- The mRNA Monthly—June 2024 Newsletter
- The mRNA Monthly—May 2024 Newsletter
- Poster: Methods for mRNA poly(A) Sizing Using RNase Digestion & Capillary Gel Electrophoresis, & Nanopore-based Sequencing
- Poster: Evaluation of Doggybone™ DNA as Template for In Vitro Transcription
- Poster: mRNA Capping Technologies – Effects on Quality Attributes, Biological Effects, and Innate Immune Stimulation
- Poster: Novel Plasmid DNA-encoded poly(A) Tails For mRNA Synthesis
- June Newsletter
- April Newsletter
- Poster: Potent anti-SARS-CoV-2 Spike Protein Immune Responses with LNP-mRNA in Mice
- Potent Immune Response with Vernal’s LNP-mRNAs
- Vernal’s First Newsletter!
- Poster: Design, Formulation, and Manufacturing of LNP-mRNA for clinically relevant applications
- Meet Vernal’s Experts at mRNA Health Conference
- Vernal Starts Construction on Vermont mRNA Facility
- Vernal welcomes Scott Vanson and JJ Bivona to the team
- Vernal Launches Preclinical LNP Formulation Service